Anti-IGF1 Receptor antibody [alphaIR3] (ab16890)

Publishing research using ab16890? Please let us know so that we can cite the reference in this datasheet.

ab16890 has been referenced in 5 publications.

  • O'Neill AF  et al. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody. Clin Cancer Res 20:678-87 (2014). PubMed: 24218512
  • Sirianni R  et al. Targeting estrogen receptor-a reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment. J Clin Endocrinol Metab 97:E2238-50 (2012). PubMed: 23074235
  • Jaquish DV  et al. IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migration. Carcinogenesis 32:1151-6 (2011). ICC/IF ; Human . PubMed: 21565828
  • Rohlik QT  et al. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Commun 149:276-81 (1987). PubMed: 2961338
  • Kull FC  et al. Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem 258:6561-6 (1983). PubMed: 6304046

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"